Archives

by in
Entry Author Date Location
Mnemosyne, Hydra, On-Q-ity, & More New England Life Sciences News 02/17/12 Boston
Energy Points, Biogen, Navinet, & More Boston Dealmakers 02/15/12 Boston
Biogen Idec Lets Stromedix Do The Hard Part 02/14/12 Boston
Biogen Buys Stromedix for $75M, Regaining Fibrosis Drug 02/14/12 Boston
Biogen Idec Acquires StroMedix for $562,500,000 02/14/12 Boston
Shout Outs for Avila From Polaris, Atlas, & the Twittersphere 01/26/12 Boston
Boston Xconomists and Area Innovators Gather for Special Xconomy Event: The Photos 10/13/11 Boston
Tweetchat on RNA Interference Upstages iPhone (Not Really, but It Was Still Fun) 10/05/11 National
What Most Biotechies Are Missing on Twitter: A Huge Networking Opportunity 09/12/11 National
BayBio’s Annual Conference, Tweet by Tweet 04/22/11 San Francisco
Stromedix Adds Debt to Finance Clinical Trial, Eliza and Google Team Up for Health IT Website, Arsanis Gets $10M, & More Boston-Area Life Sciences News 02/11/11 Boston
Stromedix Chief, After Reloading the Company Treasury, Sets Sight on Trial for Deadly Lung Disease 02/07/11 Boston
EnerNOC Acquires M2M, H3 Launches With Eisai Funding, Genzyme Talks With Sanofi Advance, & More Boston-Area Deals News 02/02/11 Boston
Clinical Data Stock Soars on FDA Approval, Amgen Buys BioVex, Stromedix Raises $2M, & More Boston-Area Life Sciences News 01/28/11 Boston
$2M Debt Funding for Stromedix 01/26/11 Boston
StroMedix Receives $2,000,000 New Financing Round 01/25/11 Boston
Hyperion Nails Pivotal Trial, ChemoCentryx Aims High Against Crohn’s, Vivus Shot Down by FDA, & More Bay Area Life Sciences News 11/05/10 San Francisco
Dendreon’s Plan to Meet Demand, Arch Banks on Ikaria IPO, RF Surgical Leaves No Sponge Behind, & More Seattle-Area Life Sciences News 11/04/10 Seattle
How I’ve Discovered Twitter Can Be a Resource, Not a Waste of Time 11/01/10 Boston
Taris Hires New CEO, Stromedix Hopes Clinical Trial Will Advance, Euthymics Hits the Ground With Series A, & More Boston-Area Life Sciences News 07/23/10 Boston
Stromedix, with Biogen Idec Roots, Seeks Exit from Regulatory Limbo 07/20/10 Boston
Gene Network Sciences Using Supercomputing to Match Patients with a Drug That Works 04/27/10 Boston
Regulus Strikes Out On Its Own, J&J Seeks “Enlight”-enment, Synta Awaits Melanoma Data, & More Boston-Area Life Sciences News 01/28/09 Boston
Stromedix Wins Patent For Lead Drug 01/23/09 Boston
Follica’s Fortunes Growing, Icahn’s Biogen Holdings Mounting, Genzyme’s Mipomersen Work Progressing, & More Life Sciences News 08/13/08 Boston
GSK Takes Sirtris and Taps Alnylam Venture, FDA Deals Genzyme Drug a Blow, Resolvyx Finances Fish-Oil Drugs, & More Life Sciences News 04/23/08 Boston
Aurora, Draper Labs, and BAE Team, IBM’s Merger Machine Steams, Lonelygirl15 Beams, & More Deals News 04/22/08 Boston
With a $25 Million Bankroll and Technology “Fully Baked” by Biogen Idec, Stromedix is Heading into the Uncharted Territory of Fibrosis 04/21/08 Boston
StroMedix Lands $25,000,000 Series B Financing Round 04/21/08 Boston
Page 1 of 1
    

Xconomy Events Across the Network

The Napa Summit: Keeping America Growing

San Francisco · 6/7/12

More Xconomy Events

Xconomy’s Most Popular

  1. ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
  2. Biotech IPOs Start to Show Some Modest Signs of Life
  3. Hey, Silicon Valley: Wake Up and Smell the Robots
  4. From MIT Entrepreneur to Tea Party Leader: The Thomas Massie Story
  5. Announcing Xconomy’s Napa Summit: Keeping America Growing

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.